Company: ACBM
Filing Date: 2025-07-02
Form Type: 8-K
Source: 0001640334-25-001097
Chunk: 2

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-07-02
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01 Financial Statements and Exhibits

(d) Exhibits.

  Exhibit                                                                                                      
  Number       Description                                                                                     
  16.1         Letter to the Securities and Exchange Commission from Prager Metis CPAs, LLC dated July1, 2025  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

  Date: July 1. 2025               ACRO BIOMEDICAL CO., LTD.  
 ──────────────────────────────────────────────────────────────
                          By:      /s/ Pao-Chi Chu            
                                   Pao-Chi Chu                
                                   Chief Executive Officer